Copycat Ozempic makers just lost a big court fight

In This Story A federal judge in Texas handed Novo Nordisk (NVO+2.41%) a big win late Thursday in its battle against cheaper versions of its blockbuster drugs Ozempic and Wegovy, rejecting a bid by compounding pharmacies to keep making the drugs while a legal challenge moves forward. In a sealed…